The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Zinman, B. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515920 · Cited by 3,655
Hyperglycemic crises in adult patients with diabetes
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009) · Diabetes Care · doi:10.2337/dc09-9032 · Cited by 2,062
Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389
Heerspink, H. J. L., Perkins, B. A., Fitchett, D. H., Husain, M., & Cherney, D. Z. I. (2016) · Circulation · doi:10.1161/circulationaha.116.021887 · Cited by 1,376
Miller, K. M., Foster, N. C., Beck, R. W., Bergenstal, R. M., DuBose, S. N., DiMeglio, L. A., Maahs, D. M., & Tamborlane, W. V. (2015) · Diabetes Care · doi:10.2337/dc15-0078 · Cited by 1,254
Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability
Service, F. J., Molnar, G. D., Rosevear, J. W., Ackerman, E., Gatewood, L. C., & Taylor, W. F. (1970) · Diabetes · doi:10.2337/diab.19.9.644 · Cited by 1,039
Glycemic Control and Excess Mortality in Type 1 Diabetes
Lind, M., Svensson, A.-M., Kosiborod, M., Gudbjörnsdottir, S., Pivodic, A., Wedel, H., Dahlqvist, S., Clements, M., & Rosengren, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408214 · Cited by 964
Sodium–Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes: A Systematic Review and Meta-analysis
Vasilakou, D., Karagiannis, T., Athanasiadou, E., Mainou, M., Liakos, A., Bekiari, E., Sarigianni, M., Matthews, D. R., & Tsapas, A. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-4-201308200-00007 · Cited by 911
Cited by
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s009 · Cited by 1,555
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s009 · Cited by 972
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s009 · Cited by 914
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s009 · Cited by 851
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s009 · Cited by 739
Metadata
- Authors
- Dandona, P., Mathieu, C., Phillip, M., Hansen, L., Griffen, S. C., Tschöpe, D., Thorén, F., Xu, J., Langkilde, A. M., Proietto, J., Stranks, S., Chen, R., O'Neal, D., Pape, A., Forbes, M., Morbey, C., Luger, A., Hanusch, U., Schnack, C., Fliesser-Goerzer, E., Hoelzl, B., Ebenbichler, C., Prager, R., Van Gaal, L., Vercammen, C., Scheen, A., Mathieu, C., Duyck, F., Nobels, F., Ruige, J., Aggarwal, N., Woo, V., St-Pierre, B., Dumas, R., Hramiak, I., Elliott, T., Krarup Hansen, T., Henriksen, J. E., Gram, J., Lihn, A., Bruun, J., Saltevo, J., Taurio, J., Strand, J., Valle, T., Nieminen, S., Pietilainen, K., Guerci, B., Hadjadj, S., Cariou, B., Verges, B., Borot, S., Penfornis, A., Schaum, T., Tschoepe, D., Marck, C., Horacek, T., Rose, L., Klausmann, G., Luedemann, J., Appelt, S., Aigner, U., Goebel, R., Behnke, T., Ziegler, A.-G., Peterfai, E., Kerenyi, Z., Oroszlan, T., Kiss, G. G., Konyves, L., Piros, G., Phillip, M., Mosenzon, O., Shehadeh, N., Adawi, F., Wainstein, J., Dotta, F., Piatti, P., Genovese, S., Consoli, A., Di Bartolo, P., Mannucci, E., Giordano, C., Lapolla, A., Aguilar, C., Esteban, A., Ruiz, B., Ramirez, G. M., Pelayo Orozco, E., Alejandro, C., de Alba, S., Medina Pech, C., Garza Ruiz, J., Sauque Reyna, L., Llamas Esperon, G., Nevarez Ruiz, L. A., Vidrio Velazquez, M., Flores Lozano, F., Gonzalez Gonzalez, J. G., Garcia-Hernandez, P. A., Araujo-Silva, R., Villeda - Espinosa, E., Mistodie, C., Popescu, D., Constantin, C., Nicolau, A., Popa, B., Timar, R., Serafinceanu, C., Pintilei, E., Soto, A., Gimenez, M., Merino-Torres, J. F., Morales, C., Mezquita, P., Jendle, J., Tengmark, B.-O., Eriksson, J., Londahl, M., Eliasson, B., Gunstone, A., Heller, S., Darzy, K., Mansell, P., Davies, M., Reed, R., Browne, D., Courtney, H., Turner, W., Blagden, M., McCrimmon, R., Bergenstal, R., Lane, W., Lucas, K., White, A., Bao, S., White, J., Jantzi, C., Rasouli, N., Ervin, W., Lewy-Alterbaum, L., Handelsman, Y., Miranda-Palma, B., Cleland, A., Fink, R., Rodbard, H., Nakhle, S., Greenberg, C., Schorr, A., Bays, H., Simmons, D., Klein, E., Kane, L., Fishman, N., Ipp, E., Garg, S., Bhargava, A., Singh, M. Z., Rosenstock, J., Thrasher, J., Warren, M., Young, L., Aroda, V., Pettus, J., Liljenquist, D., Busch, R., Dandona, P., Wise, J., Kayne, D., & Biggs, W.
- Venue
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 5
- Issue
- 11
- Pages
- 864-876
- ISSN
- 2213-8587 (ISSN-L)
- OpenAlex
- W2756104796
- Cited by
- 293
- References
- 34
- FWCI
- 29.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial. https://app.cochat.ai/papers/10.1016/s2213-8587(17)30308-x
- The paper
- Dandona, P., Mathieu, C., Phillip, M., Hansen, L., Griffen, S. C., Tschöpe, D., Thorén, F., Xu, J., Langkilde, A. M., Proietto, J., Stranks, S., Chen, R., O'Neal, D., Pape, A., Forbes, M., Morbey, C., Luger, A., Hanusch, U., Schnack, C., . . . Biggs, W. (2017). Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(17)30308-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.